Emerald Square Ventures acquires majority stake in H Clinical
The undisclosed investment will expand clinical-trial services across Latin America.
Emerald Square Ventures acquired a majority stake in H Clinical. The transaction value was not disclosed.
H Clinical will expand research-site solutions, staffing, patient recruitment, in-home trial support and procurement logistics across Latin America. The company operates through local teams in 22 countries, serving sponsors, contract research organizations and research sites.
Use of funds
Expand research site solutions, staffing, patient recruitment, in-home trial support and procurement logistics across Latin America